# Abbott Laboratories (ABT) — Q3-2022 Earnings Results

**Report date:** 2022-10-19 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABT/earnings/Q3-2022

## Post-Earnings Brief

### Headline

Abbott Laboratories Beats on EPS, Stock Down 6.54%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.15 | N/A | +26.93% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record for the earnings call, so the analysis is based solely on numerical results.

### Guidance Changes

No guidance data is available for this quarter.

### What It Means

Abbott Laboratories reported a strong EPS that exceeded expectations, but the stock fell by 6.54% in reaction. This decline may reflect investor concerns or broader market trends, as no revenue figures or guidance were provided to clarify future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABT/earnings/Q3-2022_